REMINDER: Our user survey closes on Friday, please submit your responses here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksCreightons Regulatory News (CRL)

Share Price Information for Creightons (CRL)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 25.00
Bid: 23.00
Ask: 27.00
Change: 0.00 (0.00%)
Spread: 4.00 (17.391%)
Open: 25.00
High: 25.00
Low: 25.00
Prev. Close: 25.00
CRL Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Interim Mgt Statement and Director Appointments

11 Feb 2015 07:00

RNS Number : 5714E
Creightons PLC
11 February 2015
 



Creightons Plc

(''Creightons'' or the ''Company'')

Interim Management Statement and Director Appointments

Creightons plc, a leading distributor and award winning manufacturer of personal care products and UK brand owner, today issues its interim management statement for the period from 1 October 2014 to 6 February 2015 ("the Relevant Period") and is pleased to announce that, following a re-organisation within the senior management team, three senior executives have been appointed to its Board with effect from 10 February 2015.

Interim Management Statement

The Company's financial position has continued the improvement we have been achieving over the last few years. Since the last published balance sheet (30 September 2014) there has been an increase in retained earnings as a result of profits achieved on sales in the third quarter.

Sales in the third quarter have continued to grow, particularly our branded products where we have developed and launched new product ranges. This growth has resulted in the need to extend our production capacity by investing in the resources required to support an extended second shift. This step change in costs will result in increased overhead costs whilst supporting any future growth in sales by increasing production capacity.

There is significantly increased competition in the retail market including the health and beauty sector in which we operate. This competition is resulting in increased sales volatility which makes it difficult to predict whether the sales growth achieved to date will continue.

Neither the financial information on which this statement is based nor this statement itself have been reviewed or reported upon by the Company's auditors.

Director Appointments

 

Mr. Martin Stevens is appointed as Group Deputy Managing Director. Martin is a Chartered Chemist and has worked in the cosmetics industry for 32 years with extensive experience across the personal care and household sector in Research & Development, Quality Assurance, Production and Procurement. Martin has been Technical Director at Potter & Moore Innovations Ltd (the Company's principal trading business) and Creightons Plc for the past 14 years. He has previously been Technical Director of Norit Body Care Toiletries, Technical Director at the manufacturing division of AAH Pharmaceuticals Ltd, Chief Chemist at Columbia Products Co Ltd after initially entering the industry with L'Oreal working with brands such as Lancôme and Cacharel.

 

Ms. Pippa Clark is appointed Global Marketing Director. Pippa has worked within the industry for 18 years in a wide and extensive range of sales, marketing and commercial roles across private label, branded and contract businesses. In recent years she has headed up the development of the Creightons branded portfolio growing and extending the reach of the Company's award winning brands into multiple channels and international markets whilst also overseeing the development of the strengthening private label division of the business.

 

Mr. Paul Forster is appointed Director of UK Operations. This is a new role with responsibility encompassing manufacturing, logistics and procurement. Paul has been with the Potter & Moore Innovations business for 24 years, primarily working as Chief Financial Officer but also including spells overseeing manufacturing. Previously he was Finance Director of Beauty International Fragrance Ltd (BIF), who distributed the Coty fragrance range throughout Europe and the Far East. Prior to joining BIF Paul qualified as a Chartered Accountant with Touche Ross.

 

Mr. William McIlroy, Chairman, commented ''Martin, Pippa and Paul have been instrumental in the development of the business over recent years and I am delighted to welcome them as directors of the Company and we look forward to working together in the next phase in the development of Creightons''.

 

Save as disclosed below, none of the above have any current directorships nor have they been directors of companies in the five years preceding the date of this announcement, nor are there any other matters required to be disclosed by paragraphs 9.6.13(2) to (6) of the Listing Rules.

 

Paul Forster was operations director of Potter & Moore Group in 2001 when it went into administration and was sold to Nemesis Toiletries Limited. The business undertaken by Nemesis Toiletries Limited was subsequently sold to Creightons Plc.

The Company's final results for the year to 31 March 2015 are expected to be published by 30 June 2015.

Investor enquiries should be addressed to the Company Secretary, Nicholas O'Shea, Creightons plc, 1210 Lincoln Road, Peterborough, PE4 6ND, phone +44 (0) 1733 281000.

Bernard Johnson

Managing Director

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
MSCURABRVOAUAAR
Date   Source Headline
15th Mar 202410:52 amRNSBlock listing Interim Review
7th Mar 20247:00 amRNSDirectorate Change
4th Dec 20237:00 amRNSHalf-year Report
27th Nov 20237:00 amRNSDirectorate Change
25th Sep 202311:50 amRNSDirector/PDMR Shareholding
15th Sep 20235:24 pmRNSBlock listing Interim Review
14th Sep 20239:52 amRNSResult of AGM
1st Sep 20235:17 pmRNSDirector/PDMR Shareholding
1st Sep 20235:05 pmRNSDirector/PDMR Shareholding
25th Aug 20233:32 pmRNSDirector/PDMR Shareholding
31st Jul 20232:53 pmRNSReplacement: Director/PDMR Shareholding
24th Jul 202311:54 amRNSDirector/PDMR Shareholding
7th Jul 20237:00 amRNSAudited preliminary results
31st Mar 202310:49 amRNSTotal Voting Rights
17th Mar 20237:00 amRNSBlock listing Interim Review
16th Mar 20234:35 pmRNSPrice Monitoring Extension
27th Jan 20232:05 pmRNSSecond Price Monitoring Extn
27th Jan 20232:00 pmRNSPrice Monitoring Extension
12th Jan 20232:05 pmRNSSecond Price Monitoring Extn
12th Jan 20232:00 pmRNSPrice Monitoring Extension
30th Dec 202211:05 amRNSSecond Price Monitoring Extn
30th Dec 202211:00 amRNSPrice Monitoring Extension
20th Dec 20224:40 pmRNSSecond Price Monitoring Extn
20th Dec 20224:35 pmRNSPrice Monitoring Extension
1st Dec 20227:00 amRNSHalf-year Report
29th Nov 20224:41 pmRNSSecond Price Monitoring Extn
29th Nov 20224:36 pmRNSPrice Monitoring Extension
25th Nov 20227:00 amRNSInterim Results 2022 - announcement, presentations
27th Sep 20227:00 amRNSUpdate on Emma Hardie, Trading in own shares & TVR
20th Sep 20229:22 amRNSBlock Listing Update
24th Aug 20221:01 pmRNSResult of AGM
12th Jul 20229:05 amRNSSecond Price Monitoring Extn
12th Jul 20229:00 amRNSPrice Monitoring Extension
12th Jul 20227:00 amRNSResults for year to end 31 March 2022
11th Jul 20227:00 amRNSPreliminary Results, investor/analyst presentation
4th Jul 20224:42 pmRNSTotal Voting Rights
7th Jun 20223:28 pmRNSTotal Voting Rights
3rd May 20226:09 pmRNSTotal Voting Rights
12th Apr 20224:33 pmRNSDirector/PDMR Dealing, Total Voting Rights
21st Mar 202211:37 amRNSBlock listing Interim Review
7th Mar 20229:59 amRNSTotal Voting Rights
14th Jan 20222:58 pmRNSTotal Voting Rights
30th Dec 20217:00 amRNSHalf-year Report
15th Dec 20212:52 pmRNSNotice of Interim Results & Investors Presentation
6th Dec 20215:38 pmRNSTotal Voting Rights
25th Nov 20216:18 pmRNSDirector/PDMR Shareholding and Total Voting Rights
23rd Nov 20214:49 pmRNSDirector/PDMR Shareholding
18th Nov 202111:55 amRNSDirector/PDMR Shareholding
17th Nov 20211:58 pmRNSDirector/PDMR Shareholding
15th Nov 20217:00 amRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.